Vicki Sato - BorgWarner Independent Director
| BWA Stock | USD 34.32 0.04 0.12% |
Director
Dr. Vicki L. Sato, Ph.D., is Independent Director of BorgWarner Inc. Dr. Sato is an accomplished executive and scientist with an extensive background advising and leading companies in life sciences innovation. Dr. Sato served as Professor of Management Practice at Harvard Business School from 2006 until her retirement in 2017. At Harvard, she was Founding Faculty Chair of the Blavatnik Fellowship in Life Science Entrepreneurship program. From 1992 to 2005, she was with Vertex Pharmaceuticals, initially as Chief Scientific Officer and Chair of the scientific advisory board, and subsequently as President from 2000 to 2005. Prior to joining Vertex, she was with Biogen, Inc., from 1984 to 1992, concluding her tenure there as Vice President of Research and as a member of the scientific advisory board. Dr. Sato continues to serve as a business advisor to enterprises in the biotechnology and pharmaceutical industries. She is currently a director of Bristol Myers Squibb Company and Syros Pharmaceuticals, Inc. as well as NonExecutive Chair of Denali Therapeutics, Inc., all publiclyheld companies. Previously, Dr. Sato served as a director of PerkinElmer from 2003 to 2017. In addition to her public board service, she is Chairman to privately held Vir Biotechnology, Inc. She was recently appointed cochair of the Advisory Council of LifeSci NYC, a public service group that advises New York City on matters of life science competitiveness. She is the author of numerous professional publications and received her AB, AM, and Ph.D. degrees from Harvard University since 2014.
| Age | 71 |
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Address | 3850 Hamlin Road, Auburn Hills, MI, United States, 48326 |
| Phone | 248 754 9200 |
| Web | https://www.borgwarner.com |
Vicki Sato Latest Insider Activity
Tracking and analyzing the buying and selling activities of Vicki Sato against BorgWarner stock is an integral part of due diligence when investing in BorgWarner. Vicki Sato insider activity provides valuable insight into whether BorgWarner is net buyers or sellers over its current business cycle. Note, BorgWarner insiders must abide by specific rules, including filing SEC forms every time they buy or sell BorgWarner'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Vicki Sato over six months ago Disposition of 1666 shares by Vicki Sato of Denali Therapeutics at 18.37 subject to Rule 16b-3 |
BorgWarner Management Efficiency
The company has Return on Asset of 0.0527 % which means that on every $100 spent on assets, it made $0.0527 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1592 %, implying that it generated $0.1592 on every 100 dollars invested. BorgWarner's management efficiency ratios could be used to measure how well BorgWarner manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to 0.05. In addition to that, Return On Capital Employed is expected to decline to 0.08. At present, BorgWarner's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 6.5 B, whereas Non Current Assets Total are forecasted to decline to about 4.3 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Roger Krone | Lear Corporation | 64 | |
| Nicholas Donofrio | Aptiv PLC | 75 | |
| Lawrence Zimmerman | Aptiv PLC | 77 | |
| James Barrese | Visteon Corp | 50 | |
| Peter Carlin | Adient PLC | 48 | |
| Barbara Samardzich | Adient PLC | 63 | |
| Ana Pinczuk | Aptiv PLC | 57 | |
| Colin Parris | Aptiv PLC | 59 | |
| Thomas Capo | Lear Corporation | 69 | |
| Raymond Conner | Adient PLC | 65 | |
| Naomi Bergman | Visteon Corp | 55 | |
| Nancy Cooper | Aptiv PLC | 67 | |
| Richard Clemmer | Aptiv PLC | 70 | |
| Leif Johansson | Autoliv | 70 | |
| Hasse Johansson | Autoliv | 71 | |
| Ernesto Hernandez | Dana Inc | 63 | |
| Rachel Gonzalez | Dana Inc | 51 | |
| Michael Swartz | Fox Factory Holding | N/A | |
| Jonathan Foster | Lear Corporation | 60 | |
| Joseph Boutross | LKQ Corporation | N/A | |
| Jose Gutierrez | Adient PLC | 59 | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0527 |
BorgWarner Leadership Team
Elected by the shareholders, the BorgWarner's board of directors comprises two types of representatives: BorgWarner inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BorgWarner. The board's role is to monitor BorgWarner's management team and ensure that shareholders' interests are well served. BorgWarner's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BorgWarner's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John McKernan, Independent Director | ||
| Paul Farrell, Vice President and Chief Strategy Officer | ||
| Frederic Lissalde, VP and President of Borgwarner Turbo Systems Inc and General Manager of Borgwarner Turbo Systems Inc | ||
| Sara Greenstein, Independent Director | ||
| Patrick Nolan, Vice President - Investor Relations | ||
| Harry Husted, Chief Officer | ||
| David Haffner, Independent Director | ||
| Tania Wingfield, Executive Officer | ||
| Deborah McWhinney, Independent Director | ||
| Volker Weng, Vice President, President and General Manager, Drivetrain Systems | ||
| Joseph Fadool, Vice President, President and General Manager of BorgWarner Emissions, Thermal and Turbo Systems | ||
| Michael Hanley, Independent Director | ||
| Davide Girelli, Vice President and President and General Manager, Fuel Injection Systems | ||
| Tonit JD, Chief VP | ||
| Craig Aaron, Vice President Treasurer | ||
| Tom Tan, VP China | ||
| Vicki Sato, Independent Director | ||
| Felecia Pryor, Chief Human Resource Officer, Executive Vice President | ||
| Nelda Connors, Independent Director | ||
| Dennis Cuneo, Independent Director | ||
| Alexandros Michas, Non-Executive Independent Chairman of the Board | ||
| Alex Ashmore, Vice President and President and General Manager, Aftermarket | ||
| Tonit Calaway, Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary | ||
| Isabelle McKenzie, President VP | ||
| Patrick CFA, Vice Relations | ||
| Kevin Nowlan, Chief Financial Officer, Executive Vice President | ||
| Hakan Yilmaz, Chief Technology Officer, Vice President | ||
| Shaun McAlmont, Independent Director | ||
| Stefan Demmerle, Vice President; President and General Manager of BorgWarner TorqTransfer Systems Inc | ||
| Alexis Michas, Non-Executive Independent Chairman of the Board | ||
| Amy Kulikowski, VP Officer | ||
| Eddie Sander, Director Relations | ||
| Brady Ericson, Vice President; President and General Manager of BorgWarner BERU Systems and Emissions Systems | ||
| Daniel Etue, Vice President Controller | ||
| Paul Mascarenas, Independent Director |
BorgWarner Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BorgWarner a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0527 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 10.24 B | ||||
| Shares Outstanding | 218.7 M | ||||
| Shares Owned By Insiders | 0.66 % | ||||
| Shares Owned By Institutions | 99.34 % | ||||
| Number Of Shares Shorted | 7.47 M | ||||
| Price To Earning | 17.95 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BorgWarner offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BorgWarner's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Borgwarner Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Borgwarner Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BorgWarner. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade BorgWarner Stock refer to our How to Trade BorgWarner Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Automotive Parts & Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BorgWarner. If investors know BorgWarner will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BorgWarner listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.909 | Dividend Share 0.44 | Earnings Share 4.04 | Revenue Per Share 62.37 | Quarterly Revenue Growth (0.05) |
The market value of BorgWarner is measured differently than its book value, which is the value of BorgWarner that is recorded on the company's balance sheet. Investors also form their own opinion of BorgWarner's value that differs from its market value or its book value, called intrinsic value, which is BorgWarner's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BorgWarner's market value can be influenced by many factors that don't directly affect BorgWarner's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BorgWarner's value and its price as these two are different measures arrived at by different means. Investors typically determine if BorgWarner is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BorgWarner's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.